High Tide to Become Major Player in German Medical Cannabis Market Through €27.2 Million Acquisition
The Canadian cannabis company signed an agreement to acquire a majority stake in Remexian Pharma GmbH.
The Canadian cannabis company signed an agreement to acquire a majority stake in Remexian Pharma GmbH.